Plant Genetic Systems
Corporate brand
UnclaimedPlant Genetic Systems is a Belgian plant-biotechnology company known for pioneering genetic engineering methods and insect-resistant transgenic crops.
Last updated August 31, 2026
Overview
Plant Genetic Systems (PGS) was a Belgian agricultural-biotechnology company established in Ghent in 1982 by plant scientists Marc Van Montagu and Jeff Schell. Its origins lay in research at the University of Ghent that helped establish practical methods for introducing foreign genes into plant genomes. The company became especially associated with the use of the Ti plasmid of Agrobacterium tumefaciens as a vector for plant transformation, an approach that became foundational to modern plant genetic engineering. PGS's scientific work included the transfer of a bacterial neomycin phosphotransferase gene into plant cells, producing resistance to the antibiotic kanamycin and demonstrating that selected foreign traits could be stably expressed in plants. The company also became a leading developer of insect-resistant transgenic crops. In 1985, it produced genetically engineered tobacco plants expressing insecticidal proteins derived from Bacillus thuringiensis, commonly known as Bt. This work was an early commercial and technological milestone in the development of crops designed to resist insect attack through genetic rather than conventional chemical protection. The company expanded through strategic ownership changes. AgrEvo acquired PGS in 1996. AgrEvo subsequently became part of Aventis CropScience when AgrEvo and Rhône-Poulenc Agro were combined in 2000. Bayer acquired Aventis CropScience's agricultural business in 2002, after which PGS became part of Bayer CropScience. The company is therefore best understood today as a historical and organizational component of Bayer's agricultural-biotechnology operations rather than as an independently traded company. PGS's history also includes significant public controversy. In 1999, a field trial involving AgrEvo genetically modified maize near Lyng in Norfolk, England, was targeted by Greenpeace activists; the action led to criminal proceedings involving the activists. In 2000, StarLink, a genetically modified maize product developed by PGS, was detected in numerous consumer food products in the United States. StarLink had been approved for animal feed but not for human consumption because of regulatory concerns relating to its potential allergenicity. The discovery prompted recalls, extensive testing, regulatory and commercial scrutiny, and the eventual withdrawal of the product from the market. The episode became one of the most prominent early cases illustrating the difficulty of separating genetically modified crops intended for different end uses. PGS's lasting significance rests primarily on its scientific contributions and its role in the commercialization of plant biotechnology. Its work connected university research in Ghent with industrial crop-development programs and helped advance the use of Agrobacterium-mediated transformation and Bt-based insect resistance. Although the standalone PGS identity was absorbed into successor corporate structures, its technologies and research legacy continued within the broader agricultural-science businesses of AgrEvo, Aventis CropScience, and Bayer CropScience.
History
Plant Genetic Systems emerged from plant-genetics research conducted at the University of Ghent by Marc Van Montagu and Jeff Schell. Their work helped demonstrate how the Ti plasmid of Agrobacterium tumefaciens could be used to transfer foreign genetic material into plant cells. This research provided a practical foundation for the genetic transformation of plants and made it possible to introduce, select, and express new traits in crop species. The company was founded in 1982 in Ghent, Belgium. One of the early technical achievements associated with its research was the introduction of a bacterial neomycin phosphotransferase gene into plant genomes. The resulting kanamycin resistance gave researchers a selectable marker for identifying successfully transformed cells, an important tool in the development of transgenic plants. PGS also pursued the agricultural application of genetic engineering, particularly the creation of plants able to withstand insect attack. In 1985, PGS developed genetically engineered tobacco plants expressing insecticidal proteins from Bacillus thuringiensis. These Bt proteins provided a biological defense against certain insect pests and became an important model for later commercial crop traits. Subsequent research from PGS scientists contributed to the characterization and use of Bt genes in plant biotechnology. A 1987 Nature paper describing transgenic plants protected from insect attack helped establish the scientific credibility of this approach. PGS became part of the expanding agricultural-biotechnology industry through a sequence of acquisitions. AgrEvo acquired the company in 1996. In 2000, AgrEvo and Rhône-Poulenc Agro were combined to create Aventis CropScience. Bayer then acquired Aventis CropScience's plant-biotechnology business in 2002, creating Bayer CropScience and making PGS part of Bayer's corporate agricultural platform. The company's corporate history overlapped with growing public and regulatory disputes over genetically modified crops. In 1999, a genetically modified maize trial conducted by AgrEvo near Lyng in Norfolk was targeted by Greenpeace activists. The direct action led to a subsequent trial and became part of the broader European debate over field testing and the governance of genetically modified agriculture. The most consequential controversy connected with PGS was the StarLink maize episode in the United States in 2000. StarLink contained a Bt trait and had been authorized for animal-feed use, but it had not been approved for human consumption. The trait was nevertheless detected in more than 300 consumer food products. The discovery led to product recalls, testing, regulatory scrutiny, and disruption across the grain and food-processing supply chain. PGS and its corporate owners initially pursued the possibility of obtaining authorization for human consumption, but the product was ultimately withdrawn from the market. Plant Genetic Systems is no longer generally presented as an independent corporate group. Its continuing importance is historical and technological: it was one of the early companies to translate university discoveries in plant transformation into industrial crop biotechnology, and it helped advance Bt insect resistance as a major category of genetically engineered agricultural traits.
- 2002
Integration into Bayer CropScience
[1]Bayer acquired Aventis CropScience's agricultural business, placing PGS within Bayer CropScience.
- 2000
StarLink contamination and recalls
[1]StarLink maize was detected in US consumer food products despite its lack of approval for human consumption, prompting recalls and eventual withdrawal.
- 2000
Formation of Aventis CropScience
[1]AgrEvo and Rhône-Poulenc Agro merged to form Aventis CropScience, which became the next corporate home of PGS.
- 1999
Norfolk genetically modified maize trial action
[1]A Greenpeace direct action targeted an AgrEvo genetically modified maize trial near Lyng, Norfolk, followed by legal proceedings involving the activists.
- 1996
Acquisition by AgrEvo
[1]AgrEvo acquired Plant Genetic Systems and incorporated its plant-biotechnology activities into a larger agricultural business.
- 1987
Publication on insect-protected transgenic plants
[1]PGS-associated researchers published work describing transgenic plants protected from insect attack, helping document the scientific basis of Bt crop protection.
- 1985
Development of Bt insect-tolerant tobacco
[1]PGS developed transgenic tobacco plants expressing insecticidal proteins from Bacillus thuringiensis, an early demonstration of genetically engineered insect resistance.
- 1982
Plant Genetic Systems is founded in Ghent
[1]Marc Van Montagu and Jeff Schell founded Plant Genetic Systems in Belgium to develop plant genetic-engineering technologies and applications.
Products and positioning
A pioneering European plant-biotechnology company focused on genetic engineering, crop-trait development, and insect-resistant transgenic plants.
Plant genetic engineering technology
Agrobacterium-mediated plant transformation systems
PGS was built around transformation methods using the Ti plasmid of Agrobacterium tumefaciens to introduce foreign genes into plant genomes. This technology supported the creation and selection of transgenic plant cells and formed a central part of the company's scientific and commercial identity.
Transgenic crop · 1985
Bt insect-resistant tobacco
In 1985, PGS developed genetically engineered tobacco plants that expressed insecticidal proteins from Bacillus thuringiensis. The work was an early proof of concept for protecting crops from insect damage through an internally expressed biological trait.
Genetically modified maize
StarLink maize
StarLink was a genetically modified maize product containing a Bt insect-resistance trait. It was authorized in the United States for animal-feed use but not for human consumption. Its detection in consumer food products in 2000 led to recalls, regulatory scrutiny, and its withdrawal from the market.
Controversies
2000
StarLink maize food-supply controversy
StarLink maize, which had not been approved for human consumption, was found in more than 300 US consumer food products. The discovery triggered recalls, supply-chain testing, regulatory scrutiny, and criticism of controls intended to keep feed-approved genetically modified grain separate from food channels.
Marketing campaigns
- 1999Greenpeace action against Norfolk maize trial
United Kingdom
Greenpeace activists carried out a direct action at an AgrEvo genetically modified maize trial near Lyng in Norfolk. The event reflected opposition to field testing of genetically modified crops and was followed by legal proceedings.
Outcome. The action resulted in a subsequent trial of the activists and increased public attention around genetically modified crop testing.
Brand decisions
2002
Integration into Bayer CropScienceM&ABackground
Aventis CropScience was formed in 2000 through the combination of AgrEvo and Rhône-Poulenc Agro, with PGS within the resulting organization.
Action taken
Bayer acquired Aventis CropScience's agricultural business and incorporated PGS into Bayer CropScience.
Aftermath
PGS ceased to operate primarily as an independent corporate brand and became part of Bayer's broader crop-science and agricultural-biotechnology structure.
2000
Withdrawal of StarLink from the marketStrategyBackground
StarLink maize was detected in consumer food products even though US approval covered animal-feed use rather than human consumption.
Action taken
PGS and its corporate owners initially sought approval for human consumption, but ultimately withdrew StarLink from the market after the recalls and regulatory controversy.
Aftermath
The episode became a major example of the regulatory, segregation, and supply-chain challenges associated with genetically modified crops approved for different end uses.
Recent events
- 2002
Bayer acquires Aventis CropScience[1]
M&A
Bayer acquired Aventis CropScience and established Bayer CropScience, incorporating Plant Genetic Systems into Bayer's agricultural-biotechnology operations.
- 2000
Aventis CropScience is formed[1]
M&A
AgrEvo merged with Rhône-Poulenc Agro to form Aventis CropScience, which became the corporate parent structure for PGS before Bayer's acquisition.
- 1999
Greenpeace targets genetically modified maize field trial in Norfolk[1]
Campaign · Regulation · Other
A Greenpeace direct action targeted an AgrEvo genetically modified maize trial near Lyng, Norfolk. The action was followed by criminal proceedings involving the activists.
- 1996
AgrEvo acquires Plant Genetic Systems[1]
M&A
AgrEvo acquired Plant Genetic Systems, bringing the Belgian plant-biotechnology company into a larger agricultural-chemicals and crop-science organization.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/plant-genetic-systems · Editorial policy · How profiles are compiled